Mastodon

Nefrolok-Teva (Capsules) Instructions for Use

Marketing Authorization Holder

Teva Pharmaceutical Industries, Ltd. (Israel)

Manufactured By

Med-Interplast, PUE (Republic of Belarus)

ATC Code

G04BX (Other drugs for the treatment of urological diseases)

Active Substances

Centaurii herba (DAB German Pharmacopoeia)

Levistici radix (DAB German Pharmacopoeia)

Rosmarini folium (DAB German Pharmacopoeia)

Dosage Form

Bottle OTC Icon Nefrolok-Teva Capsules

Dosage Form, Packaging, and Composition

Capsules

1 capsule
Crushed herbal drug substance (powder)
Centaury herb (Centaurii herba) 18 mg
Lovage root (Levistici officinalis radices) 18 mg
Rosemary leaves (Rosmarini officinalis folia) 18 mg

10 pcs. – blisters (3 pcs.) – cartons (30 pcs.) – Over-the-Counter
10 pcs. – blisters (6 pcs.) – cartons (60 pcs.) – Over-the-Counter

Clinical-Pharmacological Group

Herbal preparation, used for kidney and urinary tract diseases

Pharmacotherapeutic Group

Drugs used in urology; other drugs used in urology

Pharmacological Action

A combined herbal medicine that has a diuretic, antispasmodic, anti-inflammatory, and antimicrobial effect.

Indications

Complex therapy in the treatment of chronic infections of the urinary bladder (cystitis) and kidneys (pyelonephritis), in non-infectious chronic kidney inflammations (glomerulonephritis, interstitial nephritis), and as an agent that prevents the formation of urinary stones (also after the removal of urinary stones).

ICD codes

ICD-10 code Indication
N03 Chronic nephritic syndrome
N11 Chronic tubulointerstitial nephritis (chronic pyelonephritis)
N20 Calculus of kidney and ureter
N21 Calculus of lower urinary tract
N30 Cystitis
ICD-11 code Indication
GB40 Nephritic syndrome
GB55.Z Chronic tubulo-interstitial nephritis, unspecified
GB70.Z Calculus of upper urinary tract, unspecified
GB71.Z Calculus of lower urinary tract, unspecified
GC00.Z Cystitis, unspecified
GB40 Nephritic syndrome
XT8W Chronic course

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Take this medication orally.

For adults and children over 12 years of age, the standard dosage is 2 capsules three times a day.

For children aged 6 to 12 years, the dosage is 1 capsule three times a day.

Administer the capsules with a sufficient amount of fluid (at least 150-200 ml of water per dose).

Adhere to a consistent daily schedule for administration.

Swallow the capsules whole; do not chew or crush them.

Use this product as part of a complex therapy for chronic urinary tract and kidney conditions.

For the prevention of urinary stones, the duration of use is typically long-term, as directed by a physician.

In cases of acute infection, continue treatment for several days after symptoms have resolved.

Do not exceed the recommended daily dose.

If a dose is missed, take it as soon as remembered, but do not double the next dose.

The duration of therapy is determined by the treating physician based on the clinical picture and response.

Discontinue use and consult a doctor immediately if symptoms worsen or new symptoms appear.

Adverse Reactions

From the gastrointestinal tract: nausea, vomiting, diarrhea.

Possible: allergic reactions.

Contraindications

Children under 6 years of age, peptic ulcer of the stomach and duodenum in the acute phase.

Use in Pregnancy and Lactation

Use during pregnancy and breastfeeding is possible only as prescribed by a doctor, in strict accordance with the recommendations for use and after assessing the risk-benefit ratio.

Pediatric Use

Use is contraindicated in children under 6 years of age.

Special Precautions

In cases of edema caused by impaired heart or kidney function, the consumption of large amounts of fluid is contraindicated.

In cases of impaired kidney function, it should not be prescribed as monotherapy.

In the event of inflammatory kidney disease, the presence of blood in the urine, pain during urination, or acute urinary retention, it is necessary to consult a doctor immediately.

Drug Interactions

Combination with antibacterial agents is possible and appropriate.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS